List of works - Lars Carl Borris

A comparative review of the adverse effect profiles of heparins and heparinoids

scientific article

A geriatric multidisciplinary and tailor-made hospital-at-home method in nursing home residents with hip fracture

scientific article published on July 2011

A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement

scientific article

Accuracy of magnetic resonance imaging in the diagnosis of deep vein thrombosis in asymptomatic patients with injuries of the lower extremity. A pilot study

scientific article published on 01 March 2001

Apixaban versus enoxaparin for thromboprophylaxis after hip replacement

scientific article

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

scientific article

Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients

scientific article

Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis--influence of prophylaxis with a low molecular weight heparin. The Venous Thrombosis Group

scientific article

Barriers to the optimal use of anticoagulants after orthopaedic surgery

scientific article published on 08 October 2008

Biologic tolerance of two different low molecular weight heparins

scientific article published in October 1991

Biological tolerance of Logiparin, a low molecular weight heparin used in patients undergoing total hip replacement

scientific article

Biomechanical studies: science (f)or common sense?

scientific article

Clinical considerations for infant heel blood sampling

scientific article published on 01 May 1992

Clinical limitations of risk assessment models.

scientific article

Clinical profile of enoxaparin in a high-risk situation.

scientific article

Clinical trials with low molecular weight heparins in the prevention of postoperative thromboembolic complications: a meta-analysis

scientific article

Coagulation activity in elderly patients with hip fracture measured by prothrombin fragment 1 + 2 in urine

scientific article published on 15 November 2010

Collaboration between geriatricians and orthopaedic surgeons on elderly patients

scientific article

Comparison of real-time B-mode ultrasonography and bilateral ascending phlebography for detection of postoperative deep vein thrombosis following elective hip surgery. The Venous Thrombosis Group

scientific article published on 01 June 1989

Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplasty

scientific article published in July 1991

Deep-vein thrombosis prophylaxis in orthopedic surgery: hip surgery.

scientific article

Diagnosis of union of distal tibia fractures: accuracy and interobserver reliability

scientific article published on 28 November 2012

Differences in urinary prothrombin fragment 1 + 2 levels after total hip replacement in relation to venous thromboembolism and bleeding events

scientific article

Dihydroergotamine and orthostatic hypotension in elective hip surgery

scientific article published on July 1989

Dose relation in the prevention of proximal vein thrombosis with a low molecular weight heparin (tinzaparin) in elective hip arthroplasty.

scientific article

Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement

scientific article published on 12 February 2007

Effective treatment at a Danish trauma centre.

scientific article published in March 2012

Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study.

scientific article

Emerging antithrombotic agents for thromboprophylaxis, clinical potential and patient considerations

scientific article published on 5 July 2010

Experimental and clinical validation of the prophylactic antithrombotic effects of a low molecular weight heparin (enoxaparin).

scientific article

F1 + 2 and FpA in urine from patients with multiple trauma and healthy individuals. A pilot study

scientific article published on 01 August 1992

Fibrinogen and fibrin derivatives in traumatized patients: relation to injury severity and posttraumatic pulmonary dysfunction

scientific article published on 01 March 1993

Haemostatic activation in patients with head injury with and without simultaneous multiple trauma

scientific article published on 01 November 1993

How surgeons make decisions when the evidence is inconclusive.

scientific article published on 4 May 2013

Identification of a Pseudomonas aeruginosa co-producing NDM-1, VIM-5 and VIM-6 metallo-β-lactamases in Denmark using whole-genome sequencing

scientific article published on 5 December 2014

Interobserver reliability of classification and characterization of proximal humeral fractures: a comparison of two and three-dimensional CT.

scientific article published in September 2013

Interobserver variability in the treatment of little finger metacarpal neck fractures

scientific article published on 14 July 2014

Levels of thrombin--antithrombin-III complex and factor VIII activity in relation to post-operative deep vein thrombosis and influence of prophylaxis with a low-molecular-weight heparin.

scientific article published in October 1990

Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery

scientific article published on July 1996

Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use

scientific article published on 01 February 2008

Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparin

scientific article

Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparin.

scientific article published in February 1997

Markers of coagulation and fibrinolysis after fractures of the lower extremities

scientific article published on 01 March 1992

Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery

scientific article

Mobilisation after hip surgery and efficacy of thromboprophylaxis

scientific article published on 01 March 1991

New compounds in the management of venous thromboembolism after orthopedic surgery: focus on rivaroxaban.

scientific article published on January 2008

Oral rivaroxaban for symptomatic venous thromboembolism

scientific article (publication date: 23 December 2010)

Oral rivaroxaban for the treatment of symptomatic pulmonary embolism

scientific article published on 26 March 2012

Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement

scientific article

Oram's sign for hip or pelvic disorder

scientific article published in December 2009

Parenteral nutrition including amino acids fails to increase creatinine clearance in catabolic patients

scientific article published on 01 September 1989

Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery. Clinical and economic considerations

scientific article published on May 1994

Pharmacologic profile of a low molecular weight heparin (enoxaparin): experimental and clinical validation of the prophylactic antithrombotic effects

scientific article published on January 1990

Phlebography as the gold standard in thromboprophylactic studies? A multicenter interobserver variation study.

scientific article published in January 1992

Poor correlation between soluble fibrin concentrations measured by two commercially available immunoassays

scientific article published on 01 March 1996

Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement

scientific article published on 01 September 2008

Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.

scientific article

Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: the TRIFE randomized controlled trial

scientific article published on 14 January 2015

Postoperative deep vein thrombosis and plasma levels of tissue plasminogen activator inhibitor

scientific article published in November 1990

Potential influence of observer variation in thromboprophylactic trials

scientific article published in January 1992

Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trial

scientific article

Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo

scientific article published in February 1991

Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamine

scientific article published in January 1989

Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK

scientific article published on 01 July 1992

Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism

scientific article published on 26 April 2014

Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplasty

scientific article published on 27 June 2007

Radiographic loss of contact between radial head fracture fragments is moderately reliable.

scientific article

Rapid growth and early rupture of a primary mycotic aneurysm of the abdominal aorta

scientific article published on 01 October 1989

Real-time B-mode ultrasonography in the diagnosis of postoperative deep vein thrombosis in non-symptomatic high-risk patients. The Venous Thrombosis Group

scientific article published on 01 October 1990

Red blood cell transfusion strategies and health care-associated infection

scientific article published in November 2014

Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparin

scientific article published in February 1992

Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty.

scientific article published on 30 June 2009

Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.

scientific article published in June 2007

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty

scientific article

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty

scientific article

Rivaroxaban, a new, oral, direct factor Xa inhibitor for thromboprophylaxis after major joint arthroplasty

scientific article published on 01 April 2009

Role of tissue factor pathway inhibitor in post surgical deep venous thrombosis (DVT) prophylaxis in patients treated with low molecular weight heparin

scientific article published in April 1994

Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran

scientific article published on 15 May 2008

Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEE.

scientific article published in May 2012

Semuloparin for thromboprophylaxis in patients receiving chemotherapy for cancer

scientific article published in February 2012

Survival in patients undergoing total hip arthroplasty in relation to thromboprophylaxis with low molecular weight heparin: a long-term follow-up study.

scientific article published in January 1996

The cost-effectiveness of fondaparinux compared to enoxaparin as prophylaxis for deep-vein thrombosis in Denmark

scientific article published in May 2005

The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery.

scientific article published in October 2003

The economics of venous thromboembolism prophylaxis: a primer for clinicians.

scientific article published on December 2003

The value of the enzygnost TAT test in the diagnosis of postoperative deep vein thrombosis after hip surgery. The Venous Thrombosis Group

scientific article published in June 1989

Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verification.

scientific article published on 13 May 2013

Thromboembolic complications after arthroscopy of the knee

scientific article published on January 1993

Thromboprophylaxis with low molecular weight heparin after major orthopaedic surgery is cost effective.

scientific article published in January 1996

Thrombosis prophylaxis in hip arthroplasty

scientific article published on 01 December 1988

Treatment of femoral neck fractures in Denmark

scientific article published in September 2008

Ultrasonic diagnosis of deep venous thrombosis

scientific article published in July 1989

Ultrasound for diagnosis of scaphoid fractures

scientific article published on 01 August 2000

Urinary Prothrombin Fragment 1+2 in relation to Development of Non-Symptomatic and Symptomatic Venous Thromboembolic Events following Total Knee Replacement

scientific article

Use of the low-molecular-weight heparin reviparin to prevent deep-vein thrombosis after leg injury requiring immobilization

scientific article published in September 2002

Venography in deep venous thrombosis: postoperative screening of patients in prophylaxis studies.

scientific article published in March 1993

Venography used for deep vein thrombosis screening of asymptomatic patients undergoing total hip replacement

scientific article published on 01 January 1993

[Low molecular heparin in prevention of thrombosis in orthopedic surgery]

scientific article published on 01 April 1993

[Low-molecular weight heparin. A new agent to prevent thrombosis]

scientific article published on 01 May 1989

[Prevention of thrombosis in hip alloplasty]

scientific article published on 01 February 2001

[Tillaux fracture and fracture of the lateral malleolus with no medial soreness]

scientific article published on 01 August 2011

[Tinzaparin, a low molecular weight heparin]

scientific article published on 01 December 1992

List of works by Lars Carl Borris

A comparative review of the adverse effect profiles of heparins and heparinoids

A geriatric multidisciplinary and tailor-made hospital-at-home method in nursing home residents with hip fracture

A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement

Accuracy of magnetic resonance imaging in the diagnosis of deep vein thrombosis in asymptomatic patients with injuries of the lower extremity. A pilot study

Apixaban versus enoxaparin for thromboprophylaxis after hip replacement

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients

Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis--influence of prophylaxis with a low molecular weight heparin. The Venous Thrombosis Group

Barriers to the optimal use of anticoagulants after orthopaedic surgery

Biologic tolerance of two different low molecular weight heparins

Biological tolerance of Logiparin, a low molecular weight heparin used in patients undergoing total hip replacement

Biomechanical studies: science (f)or common sense?

Clinical considerations for infant heel blood sampling

Clinical limitations of risk assessment models.

Clinical profile of enoxaparin in a high-risk situation.

Clinical trials with low molecular weight heparins in the prevention of postoperative thromboembolic complications: a meta-analysis

Coagulation activity in elderly patients with hip fracture measured by prothrombin fragment 1 + 2 in urine

Collaboration between geriatricians and orthopaedic surgeons on elderly patients

Comparison of real-time B-mode ultrasonography and bilateral ascending phlebography for detection of postoperative deep vein thrombosis following elective hip surgery. The Venous Thrombosis Group

Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplasty

Deep-vein thrombosis prophylaxis in orthopedic surgery: hip surgery.

Diagnosis of union of distal tibia fractures: accuracy and interobserver reliability

Differences in urinary prothrombin fragment 1 + 2 levels after total hip replacement in relation to venous thromboembolism and bleeding events

Dihydroergotamine and orthostatic hypotension in elective hip surgery

Dose relation in the prevention of proximal vein thrombosis with a low molecular weight heparin (tinzaparin) in elective hip arthroplasty.

Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement

Effective treatment at a Danish trauma centre.

Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty--the Danish Prolonged Prophylaxis (DaPP) Study.

Emerging antithrombotic agents for thromboprophylaxis, clinical potential and patient considerations

Experimental and clinical validation of the prophylactic antithrombotic effects of a low molecular weight heparin (enoxaparin).

F1 + 2 and FpA in urine from patients with multiple trauma and healthy individuals. A pilot study

Fibrinogen and fibrin derivatives in traumatized patients: relation to injury severity and posttraumatic pulmonary dysfunction

Haemostatic activation in patients with head injury with and without simultaneous multiple trauma

How surgeons make decisions when the evidence is inconclusive.

Identification of a Pseudomonas aeruginosa co-producing NDM-1, VIM-5 and VIM-6 metallo-β-lactamases in Denmark using whole-genome sequencing

Interobserver reliability of classification and characterization of proximal humeral fractures: a comparison of two and three-dimensional CT.

Interobserver variability in the treatment of little finger metacarpal neck fractures

Levels of thrombin--antithrombin-III complex and factor VIII activity in relation to post-operative deep vein thrombosis and influence of prophylaxis with a low-molecular-weight heparin.

Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery

Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use

Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparin

Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparin.

Markers of coagulation and fibrinolysis after fractures of the lower extremities

Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery

Mobilisation after hip surgery and efficacy of thromboprophylaxis

New compounds in the management of venous thromboembolism after orthopedic surgery: focus on rivaroxaban.

Oral rivaroxaban for symptomatic venous thromboembolism

Oral rivaroxaban for the treatment of symptomatic pulmonary embolism

Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement

Oram's sign for hip or pelvic disorder

Parenteral nutrition including amino acids fails to increase creatinine clearance in catabolic patients

Perioperative thrombosis prophylaxis with low molecular weight heparins in elective hip surgery. Clinical and economic considerations

Pharmacologic profile of a low molecular weight heparin (enoxaparin): experimental and clinical validation of the prophylactic antithrombotic effects

Phlebography as the gold standard in thromboprophylactic studies? A multicenter interobserver variation study.

Poor correlation between soluble fibrin concentrations measured by two commercially available immunoassays

Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement

Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.

Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture: the TRIFE randomized controlled trial

Postoperative deep vein thrombosis and plasma levels of tissue plasminogen activator inhibitor

Potential influence of observer variation in thromboprophylactic trials

Preoperative enoxaparin versus postoperative semuloparin thromboprophylaxis in major abdominal surgery: a randomized controlled trial

Prevention of thromboembolism in 190 hip arthroplasties. Comparison of LMW heparin and placebo

Prevention of thromboembolism in hip-fracture patients. Comparison of low-dose heparin and low-molecular-weight heparin combined with dihydroergotamine

Prevention of venous thromboembolism. European Consensus Statement, 1-5 November 1991, developed at Oakley Court Hotel, Windsor, UK

Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism

Prothrombin fragment 1+2 in urine as an indicator of sustained coagulation activation after total hip arthroplasty

Radiographic loss of contact between radial head fracture fragments is moderately reliable.

Rapid growth and early rupture of a primary mycotic aneurysm of the abdominal aorta

Real-time B-mode ultrasonography in the diagnosis of postoperative deep vein thrombosis in non-symptomatic high-risk patients. The Venous Thrombosis Group

Red blood cell transfusion strategies and health care-associated infection

Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparin

Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty.

Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.

Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty

Rivaroxaban, a new, oral, direct factor Xa inhibitor for thromboprophylaxis after major joint arthroplasty

Role of tissue factor pathway inhibitor in post surgical deep venous thrombosis (DVT) prophylaxis in patients treated with low molecular weight heparin

Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran

Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEE.